YOLFTbeta
Conavi Medical Corp.

Conavi Medical Corp.

CNVI · V · Healthcare / Medical Devices

0.12CAD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.12
Open0.12
Day Range0.12 – 0.12
52-Week Range0.1425 – 0.70
Volume3.50K
Market Cap20.70M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.24
Dividend Yield0.00%
50-Day Avg0.1713
200-Day Avg0.3136

About

Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Thomas Looby
  • Employees0
  • Headquarters293 Lesmill Road, Toronto, ON, Canada, M3B 2V1, Canada
  • Websitehttps://www.conavi.com/novasight/

Leadership

  • Mr. Thomas LoobyCEO & Director · b. 1972
  • Dr. Amandeep Singh ThindCo-Founder & CTO · b. 1980
  • Mr. Mark QuickChief Financial Officer
  • John LefavourVice President of Operations
  • Mr. Travis MoreVice President of Human Resources · b. 1970

Financials

Income Statement

Currency: CAD2024-09-302025-09-30
Total Revenue2.16M9.12M
Growth (%)-+322.12%
Cost of Revenue2.11M1.50M
Gross Profit53.00K7.63M
Gross Margin2.45%83.61%
Operating Expense26.29M22.48M
Operating Income-26.23M-14.85M
Operating Margin-1213.93%-162.82%
EBITDA-34.61M-8.02M
EBITDA Margin-1601.67%-87.89%
Net Income-43.62M-20.52M
Net Income Margin-2018.28%-224.91%
R&D17.94M15.27M
R&D as % of Total Revenue830.17%167.42%
Interest Expense8.02M11.69M
Interest Expense % of Total Revenue370.94%128.11%

Balance Sheet

Currency: CAD2024-09-302025-09-30
Total Assets8.56M12.44M
Total Liabilities94.39M30.47M
Total Equity-85.83M-18.03M
Cash436.00K5.84M
Net Debt45.93M12.53M

Cash Flow

Currency: CAD2024-09-302025-09-30
Operating Cash Flow-20.15M-25.10M
Financing Cash Flow7.26M26.93M
Capital Expenditure849.00K183.00K
Free Cash Flow-21.00M-25.28M
FCF to OCF104.21%100.73%

Earnings

Report DateAug 29, 2025Dec 29, 2025Dec 31, 2026
EPS Estimate-0.08-0.08-
EPS Actual-0.05-0.27-
Surprise37.50%-237.50%-
TimingPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap20.70M
Enterprise Value39.20M
Trailing P/E0.00
Forward P/E0.00
Price / Sales24.50
Price / Book0.00
EPS-0.24
Book Value-0.189
Revenue (TTM)845.00K
Gross Profit (TTM)812.00K
EBITDA-20.71M
Profit Margin0.00%
Operating Margin-4918.46%
Return on Equity0.00%
Return on Assets-99.95%
Shares Outstanding137.99M
Shares Float103.94M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%